Dashboard
Manage Tickers

OLMA Olema Pharmaceuticals, Inc.

Nasdaq olema.com


$ 8.42 $ -0.55 (-6.13 %)    

Monday, 03-Nov-2025 15:59:56 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 629.78 $ -3.11 (-0.49 %)
DIA $ 472.70 $ -2.66 (-0.56 %)
SPY $ 681.88 $ -2.29 (-0.33 %)
TLT $ 89.68 $ 0.07 (0.08 %)
GLD $ 366.72 $ 0.05 (0.01 %)
$ 8.42
$ 9.00
$ 8.01 x 125
$ 11.00 x 30
$ 8.34 - $ 9.24
$ 2.86 - $ 13.51
792,953
na
721.83M
$ 1.91
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-11-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 03-18-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 03-11-2024 12-31-2023 10-K
8 11-07-2023 09-30-2023 10-Q
9 08-08-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 03-09-2023 12-31-2022 10-K
12 11-08-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-09-2022 03-31-2022 10-Q
15 02-28-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-10-2021 06-30-2021 10-Q
18 05-11-2021 03-31-2021 10-Q
19 03-17-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

olema-pharmaceuticals-to-present-a-trial-in-progress-poster-for-its-phase-3-opera-02-trial-at-2025-san-antonio-breast-cancer-symposium
Olema Pharmaceuticals To Present A Trial-I...
10/30/2025 20:36:13

Olema Pharmaceuticals, Inc. (("Olema" or "Olema Oncology", NASDAQ:OLMA), a clinical-stage biopharmaceutical com...

olema-pharmaceuticals-exelixis-genmab-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
Olema Pharmaceuticals, Exelixis, Genmab An...
10/20/2025 12:10:45

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
10/20/2025 12:08:17

hc-wainwright--co-reiterates-buy-on-olema-pharmaceuticals-maintains-28-price-target
HC Wainwright & Co. Reiterates Buy on Olem...
10/20/2025 11:58:03

HC Wainwright & Co. analyst Emily Bodnar reiterates Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and maintains $28 pri...

why-delcath-systems-shares-are-trading-higher-by-over-14-here-are-20-stocks-moving-premarket
Why Delcath Systems Shares Are Trading Hig...
10/20/2025 09:10:06

reported-saturday-olema-oncology-reports-155-month-median-progression-free-survival-with-palazestrant-plus-ribociclib-in-er-positive-her2-negative-metastatic-breast-cancer-at-esmo-2025
Reported Saturday, Olema Oncology Reports ...
10/20/2025 08:26:25

Palazestrant in combination with ribociclib demonstrated encouraging activity across all dose cohorts and subgroupsMedian PFS w...

guggenheim-initiates-coverage-on-olema-pharmaceuticals-with-buy-rating-announces-price-target-of-20
Guggenheim Initiates Coverage On Olema Pha...
10/08/2025 12:44:45

Guggenheim analyst Brad Canino initiates coverage on Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy rating and announces Pri...

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
09/05/2025 17:06:13

oppenheimer-maintains-outperform-on-olema-pharmaceuticals-maintains-22-price-target
Oppenheimer Maintains Outperform on Olema ...
09/03/2025 18:55:24

Oppenheimer analyst Matthew Biegler maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Outperform and maintains $22 price ...

Core News & Articles
Olema Oncology Announces Trial Agreement W...
09/02/2025 11:06:11

jp-morgan-maintains-overweight-on-olema-pharmaceuticals-raises-price-target-to-29
JP Morgan Maintains Overweight on Olema Ph...
08/14/2025 15:36:14

JP Morgan analyst Anupam Rama maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Overweight and raises the price target fr...

citigroup-maintains-buy-on-olema-pharmaceuticals-raises-price-target-to-21
Citigroup Maintains Buy on Olema Pharmaceu...
08/12/2025 11:28:08

Citigroup analyst Yigal Nochomovitz maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and raises the price target fro...

olema-pharmaceuticals-q2-eps-051-misses-038-estimate
Olema Pharmaceuticals Q2 EPS $(0.51) Misse...
08/11/2025 20:14:35

Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate ...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
06/02/2025 17:06:00

goldman-sachs-maintains-buy-on-olema-pharmaceuticals-lowers-price-target-to-18
Goldman Sachs Maintains Buy on Olema Pharm...
05/14/2025 15:06:37

Goldman Sachs analyst Richard Law maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and lowers the price target from ...

oppenheimer-maintains-outperform-on-olema-pharmaceuticals-lowers-price-target-to-22
Oppenheimer Maintains Outperform on Olema ...
05/14/2025 14:28:03

Oppenheimer analyst Matthew Biegler maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Outperform and lowers the price tar...

olema-pharmaceuticals-q1-eps-036-beats-051-estimate
Olema Pharmaceuticals Q1 EPS $(0.36) Beats...
05/13/2025 20:04:58

Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of...

why-sable-offshore-shares-are-trading-higher-by-13-here-are-20-stocks-moving-premarket
Why Sable Offshore Shares Are Trading High...
05/12/2025 09:13:23

hc-wainwright--co-reiterates-buy-on-olema-pharmaceuticals-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Olem...
04/28/2025 12:10:55

HC Wainwright & Co. analyst Emily Bodnar reiterates Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and maintains $30 pri...

why-sangamo-therapeutics-shares-are-trading-higher-by-around-40-here-are-20-stocks-moving-premarket
Why Sangamo Therapeutics Shares Are Tradin...
04/04/2025 09:20:41

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION